Literature DB >> 23462764

FDA committee: More restrictions needed on hydrocodone combination products.

Bridget M Kuehn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23462764     DOI： 10.1001/jama.2013.1609

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Prescription Drug Monitoring Program Mandates: Impact On Opioid Prescribing And Related Hospital Use.

Authors:  Hefei Wen; Jason M Hockenberry; Philip J Jeng; Yuhua Bao
Journal:  Health Aff (Millwood)       Date:  2019-09       Impact factor: 6.301

2.  Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease.

Authors:  Roseann S Gammal; Kristine R Crews; Cyrine E Haidar; James M Hoffman; Donald K Baker; Patricia J Barker; Jeremie H Estepp; Deqing Pei; Ulrich Broeckel; Winfred Wang; Mitchell J Weiss; Mary V Relling; Jane Hankins
Journal:  Pediatrics       Date:  2016-07       Impact factor: 7.124

3.  Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees.

Authors:  Hefei Wen; Jason M Hockenberry
Journal:  JAMA Intern Med       Date:  2018-05-01       Impact factor: 21.873

4.  Potential Acetaminophen and Opioid Overdoses in Young Children Prescribed Combination Acetaminophen/Opioid Preparations.

Authors:  William T Basco; Sandra S Garner; Myla Ebeling; Thomas C Hulsey; Kit Simpson
Journal:  Pediatr Qual Saf       Date:  2016-12-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.